NO20022776D0 - Substituerte bisindolylmaleimider for inhibering av celleproliferasjon - Google Patents

Substituerte bisindolylmaleimider for inhibering av celleproliferasjon

Info

Publication number
NO20022776D0
NO20022776D0 NO20022776A NO20022776A NO20022776D0 NO 20022776 D0 NO20022776 D0 NO 20022776D0 NO 20022776 A NO20022776 A NO 20022776A NO 20022776 A NO20022776 A NO 20022776A NO 20022776 D0 NO20022776 D0 NO 20022776D0
Authority
NO
Norway
Prior art keywords
cell proliferation
inhibit cell
bisindolylmaleimides
substituted
substituted bisindolylmaleimides
Prior art date
Application number
NO20022776A
Other languages
English (en)
Other versions
NO322240B1 (no
NO20022776L (no
Inventor
Nader Fotouhi
Emily Aijun Liu
Allen John Lovey
John Guilfoyle Mullin Jr
Guiseppe Federico Weber
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of NO20022776L publication Critical patent/NO20022776L/no
Publication of NO20022776D0 publication Critical patent/NO20022776D0/no
Publication of NO322240B1 publication Critical patent/NO322240B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/572—Five-membered rings
    • C07F9/5728—Five-membered rings condensed with carbocyclic rings or carbocyclic ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
    • C07F9/65583—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system each of the hetero rings containing nitrogen as ring hetero atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
NO20022776A 1999-12-16 2002-06-11 Substituerte bisindolylmaleimider, deres fremstilling, farmasoytiske preparater inneholdende slike, samt anvendelse av slike forbindelser for fremstilling av medikamenter for inhibering av celleproliferasjon NO322240B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US17105199P 1999-12-16 1999-12-16
PCT/EP2000/012559 WO2001044234A1 (en) 1999-12-16 2000-12-12 Substituted bisindolylmaleimides for the inhibition of cell proliferation

Publications (3)

Publication Number Publication Date
NO20022776L NO20022776L (no) 2002-06-11
NO20022776D0 true NO20022776D0 (no) 2002-06-11
NO322240B1 NO322240B1 (no) 2006-09-04

Family

ID=22622296

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20022776A NO322240B1 (no) 1999-12-16 2002-06-11 Substituerte bisindolylmaleimider, deres fremstilling, farmasoytiske preparater inneholdende slike, samt anvendelse av slike forbindelser for fremstilling av medikamenter for inhibering av celleproliferasjon

Country Status (33)

Country Link
US (1) US6313143B1 (no)
EP (1) EP1242408B1 (no)
JP (2) JP2003516986A (no)
KR (1) KR100507422B1 (no)
CN (1) CN1229374C (no)
AR (1) AR029415A1 (no)
AT (1) ATE306484T1 (no)
AU (1) AU783616B2 (no)
BR (1) BRPI0016329B8 (no)
CA (1) CA2392902C (no)
CO (1) CO5050293A1 (no)
CZ (1) CZ304130B6 (no)
DE (1) DE60023182T2 (no)
ES (1) ES2249314T3 (no)
GC (1) GC0000265A (no)
HK (1) HK1054385B (no)
HR (1) HRP20020513B1 (no)
HU (1) HU230003B1 (no)
IL (2) IL150128A0 (no)
JO (1) JO2296B1 (no)
MA (1) MA26856A1 (no)
MX (1) MXPA02005560A (no)
MY (1) MY126998A (no)
NO (1) NO322240B1 (no)
NZ (1) NZ519173A (no)
PE (1) PE20011034A1 (no)
PL (1) PL200243B1 (no)
RS (1) RS50449B (no)
RU (1) RU2264398C2 (no)
TW (1) TWI274752B (no)
UY (1) UY26485A1 (no)
WO (1) WO2001044234A1 (no)
ZA (1) ZA200204258B (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002102373A1 (en) * 2001-06-15 2002-12-27 F. Hoffmann-La Roche Ag Method for administration of cancer therapeutic
EP1441772A2 (en) * 2001-10-29 2004-08-04 Nektar Therapeutics Al, Corporation Polymer conjugates of protein kinase c inhibitors
US9107911B2 (en) 2010-01-07 2015-08-18 Alkermes Pharma Ireland Limited Prodrugs of heteraromatic compounds
EP2474541A1 (en) * 2010-12-23 2012-07-11 Johannes- Gutenberg-Universität Mainz Conjugated 3-(indolyl)- and 3-(azaindolyl)-4-arylmaleimide compounds and their use in tumor treatment

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ227850A (en) 1988-02-10 1991-11-26 Hoffmann La Roche Indole substituted pyrrole derivatives; preparatory process and medicaments for use against inflammatory immunological, bronchopulmonary or vascular disorders
GB9416467D0 (en) * 1994-08-13 1994-10-05 Wellcome Found Compounds for use in medicine
CN1304058C (zh) * 1996-03-12 2007-03-14 Pg－Txl有限公司 水溶性紫杉醇产品
TW517067B (en) * 1996-05-31 2003-01-11 Hoffmann La Roche Interferon conjugates
PE91498A1 (es) * 1996-07-29 1998-12-22 Hoffmann La Roche Pirroles sustituidos
PE91598A1 (es) 1996-07-29 1998-12-24 Hoffmann La Roche Pirroles sustituidos
PE91698A1 (es) 1996-07-29 1998-12-24 Hoffmann La Roche Pirroles sustituidos
JP2002500184A (ja) * 1998-01-09 2002-01-08 アリゾナ ボード オブ リーゼンツ フェンスタチンとそのプロドラッグの合成
TR200002580T2 (tr) * 1998-03-17 2000-11-21 F.Hoffmann-La Roche Ag Hücre çoğalmasının engellenmesinde kullanılan ikameli bisindolimaleimitler
US6350786B1 (en) * 1998-09-22 2002-02-26 Hoffmann-La Roche Inc. Stable complexes of poorly soluble compounds in ionic polymers
JP2003511449A (ja) * 1999-10-12 2003-03-25 エフ．ホフマン−ラ ロシュ アーゲー 癌の処理のための抗増殖剤としての置換されたピロール

Also Published As

Publication number Publication date
NO322240B1 (no) 2006-09-04
CZ304130B6 (cs) 2013-11-13
HU230003B1 (en) 2015-04-28
AU783616B2 (en) 2005-11-17
ES2249314T3 (es) 2006-04-01
ZA200204258B (en) 2003-08-28
MA26856A1 (fr) 2004-12-20
HRP20020513A2 (en) 2004-08-31
IL150128A (en) 2006-06-11
UY26485A1 (es) 2001-06-29
US6313143B1 (en) 2001-11-06
JP4763623B2 (ja) 2011-08-31
PL200243B1 (pl) 2008-12-31
CA2392902C (en) 2009-01-13
DE60023182D1 (de) 2006-02-23
MY126998A (en) 2006-11-30
CN1229374C (zh) 2005-11-30
WO2001044234A1 (en) 2001-06-21
JO2296B1 (en) 2005-09-12
AR029415A1 (es) 2003-06-25
EP1242408A1 (en) 2002-09-25
BR0016329A (pt) 2002-08-27
GC0000265A (en) 2006-11-01
NO20022776L (no) 2002-06-11
BRPI0016329B8 (pt) 2021-05-25
ATE306484T1 (de) 2005-10-15
RU2002119209A (ru) 2004-01-10
KR100507422B1 (ko) 2005-08-10
PE20011034A1 (es) 2001-10-12
TWI274752B (en) 2007-03-01
HK1054385A1 (en) 2003-11-28
NZ519173A (en) 2004-06-25
HK1054385B (zh) 2006-02-17
RU2264398C2 (ru) 2005-11-20
EP1242408B1 (en) 2005-10-12
HUP0203696A3 (en) 2004-01-28
RS50449B (sr) 2010-03-02
CZ20022447A3 (cs) 2003-06-18
CO5050293A1 (es) 2001-06-27
HUP0203696A2 (hu) 2003-03-28
DE60023182T2 (de) 2006-07-06
AU2008201A (en) 2001-06-25
JP2007153905A (ja) 2007-06-21
KR20020063215A (ko) 2002-08-01
MXPA02005560A (es) 2002-09-02
BR0016329B1 (pt) 2013-03-19
CA2392902A1 (en) 2001-06-21
CN1409709A (zh) 2003-04-09
PL355856A1 (en) 2004-05-31
YU43302A (sh) 2005-03-15
JP2003516986A (ja) 2003-05-20
IL150128A0 (en) 2002-12-01
HRP20020513B1 (en) 2006-10-31

Similar Documents

Publication Publication Date Title
DE10066271B8 (de) Solarzelle
ATE260248T1 (de) Zellproliferation inhibitoren
EE200300088A (et) Imidasolo-5-üül-2-anilino-pürimidiinid raku proliferatsiooni inhibitsiooni agensitena
DE60018357D1 (de) Dachlastträger
EE200200224A (et) Uudsed ühendid
NO20004579D0 (no) Substituerte bisindolymaleimider for inhibering av celle- proliferering
DE60019834D1 (de) Seriell - Parallel Konverter Schaltung
DK0915872T3 (da) Substituerede bisindolylmaleimider til inhibering af celleproliferation
NO20022776L (no) Substituerte bisindolylmaleimider for inhibering av celleproliferasjon
DE60009296D1 (de) Substituierte purine-derivate als zell-adhäsionhemmer
DE69907618D1 (de) Störunanfälliges Lasersystem
DE60013868D1 (de) Leitfähige zusammensetzung
PT1253917E (pt) Utilizacao de compostos de 4-amino-1-fenilbutan-2-o1 substituidos como medicamentos
IT1313295B1 (it) Foglia per confezionare oggetti piccoli
DE29905187U1 (de) Solar-Dachkonstruktion
DE29903244U1 (de) Verteilergestell
NO20020920L (no) Bruk av leptin for å hemme endotelisk celleformering
DE29904117U1 (de) Sammelschienenträger
ID28575A (id) Semprit untuk sekali pakai
FI990530A0 (fi) Peiterakenne
FI4050U1 (fi) Biojäteastia
SE9902007D0 (sv) Solfångare
FI4267U1 (fi) Teline
SE9902764D0 (sv) Novel compounds
SE9901118D0 (sv) Novel compounds

Legal Events

Date Code Title Description
MK1K Patent expired